Showing 2,676 results

Filters Content type: News, Editors' picks, About HIV Topic: Hepatitis & HIV

Hepatitis A, B and C are viral infections that can damage the liver and cause serious illnesses. Co-infection with HIV and hepatitis B or C is quite common. Safe and effective treatments are available.

New & experimental hepatitis C treatment

Sofosbuvir/ledipasvir co-formulation cures more than 90% of treatment-naive and retreated genotype 1 patients

News
14 April 2014
New & experimental hepatitis C treatment

Sofosbuvir + simeprevir dual therapy shows high cure rates for hepatitis C patients with or without cirrhosis

News
14 April 2014
Epidemiology

Viral hepatitis more deadly than HIV in Europe

Editor's pick
Science Daily
14 April 2014
Hepatitis C treatment

European liver specialists recommend 'mix-and-match' approach to new hepatitis C drugs

News
11 April 2014
Activism & civil society

International Liver Conference: activists demand affordable hepatitis C treatment

Editor's pick
HepCoalition
11 April 2014
Pharmaceutical industry

U.S. drug industry group defends price of Gilead hepatitis drug

Editor's pick
Reuters
11 April 2014
New & experimental hepatitis C treatment

Sofosbuvir/ledipasvir produces early cure for 100% of people with HIV and HCV co-infection

News
11 April 2014
New & experimental hepatitis C treatment

Sofosbuvir/ledipasvir is safe and effective for relapsers and hard-to-treat patients

News
11 April 2014
New & experimental hepatitis C treatment

88% of previous relapsers achieve hepatitis C cure with simeprevir-based triple therapy

News
10 April 2014
Hepatitis C treatment

AbbVie interferon-free regimen cures 96% of treatment-experienced genotype 1 hepatitis C infections

News
10 April 2014
New & experimental hepatitis C treatment

Egypt: New Treatments May Defuse Viral Hepatitis Time Bomb

Editor's pick
Inter Press Service
10 April 2014
PrEP science

PROUD UK PrEP study completes enrolment – first data give participants' background and risk factors

News
9 April 2014
Hepatitis C treatment

WHO recommends global use of newest hepatitis C drugs, urges price reductions

News
9 April 2014
Hepatitis C treatment

WHO joins clamour to make new hepatitis C pills affordable

Editor's pick
Reuters
9 April 2014
Hepatitis C treatment

WHO issues its first hepatitis C treatment guidelines

Editor's pick
World Health Organization
9 April 2014
Hepatitis C symptoms & diagnosis

WHO Hepatitis Treatment Guidelines: UNITAID Urges Efforts to Improve Diagnosis as Key to Increase Access to Medicines

Editor's pick
UNITAID
9 April 2014
Pharmaceutical industry

Gilead Sciences: How serious is the pricing problem?

Editor's pick
Barron's
9 April 2014
Access to healthcare

Gilead aims to license hepatitis C drug to 3-4 Indian firms

Editor's pick
Reuters
9 April 2014
Pharmaceutical industry

Express Scripts Raises Pressure on Gilead for Drug Price

Editor's pick
Bloomberg
8 April 2014
Hepatitis C transmission & prevention

First European Conference on Hepatitis C and Drug Use, Berlin, 23-24 October 2014

Editor's pick
EATG
7 April 2014
Hepatitis C treatment

Costs to public of $84,000 hep C drug ‘outrageous' - Kaiser Permanente

Editor's pick
Reuters
3 April 2014
Hepatitis C treatment

Push Comes To Shove: Gilead's $1,000 Pill Could Hurt Insurer Earnings

Editor's pick
Forbes
31 March 2014
Hepatitis C treatment

Gilead says has discounted hepatitis C drug for some health plans

Editor's pick
Reuters
31 March 2014
Hepatitis C transmission & prevention

Eliminating hepatitis C – an ambitious but achievable goal

Editor's pick
The Conversation
28 March 2014